Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease
Therapeutic Advances in Cardiovascular Disease · 2024
DOI: 10.1177/17539447241306936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2024. Verfasst von Wann Jia Loh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore 529889, Singapore. Hauptthemen laut MEDLINE: Lipoprotein(a), Myocardial Ischemia, Asian People, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NOVARTIS Singapore.
Abstract (Originalsprache)
Background
Elevated lipoprotein(a) [Lp(a)] is a common hyperlipidaemic condition with strong genetic predisposition and is independently associated with ischaemic heart disease (IHD). A Mendelian randomisation study has suggested that elevated Lp(a) is likely to confer similar causal risks as heterozygous familial hypercholesterolemia for premature IHD. We aimed to characterise the clinical profiles of admitted patients with IHD with at least one Lp(a) measurement. We also investigated whether elevated Lp(a) concentration was associated with premature onset of IHD.
Methods
This is a descriptive, non-interventional, retrospective study with data from a single tertiary hospital IHD Lp(a) cohort in Singapore, which consecutively recruited 521 patients with IHD admitted to the hospital.
Results
A total of 82.2% were men, 46.6% had newly diagnosed IHD and 10% had premature IHD. The median Lp(a) levels was 35.2 nmol/L. 70.8% of patients had normal Lp(a) concentrations (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore 529889, Singapore.
- Duke-NUS Medical School, Singapore, Singapore.
- Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
- Novartis (Singapore) Pte Ltd, Singapore, Singapore.
- Department of Cardiology, Changi General Hospital, Singapore, Singapore.
ORCID-Profile: Wann Jia Loh
Förderung
- NOVARTIS Singapore
Zitieren
APA
Loh, W. J., Teo, C. B., Simon, O., & Yeo, C. (2024). Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447241306936
Vancouver
Loh WJ, Teo CB, Simon O, Yeo C. Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease. Therapeutic Advances in Cardiovascular Disease. 2024. doi:10.1177/17539447241306936
BibTeX
@article{Loh2024,
author = {Loh, Wann Jia and Teo, Chong Boon and Simon, Oliver and Yeo, Colin},
title = {Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2024},
doi = {10.1177/17539447241306936}
}
EUVIMED